PROVEN MEDICINES ... SAFER THERAPIES

News/events

1/11/2010		KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP106 for ADHD
10/22/2009		KemPharm, Inc. Announces Initiation of Phase 1 Trial of KP106 for ADHD
9/16/2009		KemPharm, Inc. Expands Prodrug Pipeline with Candidate for Treatment of Pain and Closes Series B Financing

11/11/2009		KemPharm's Vice President of Corporate Affairs honored with Iowa's Women of Innovation Award
9/9/2009		DeWaay Backs Consumer Health Advisers From Debut VC Fund
8/15/2009		DeWaay launches $10 million venture fund
1/21/2009		I-Bank Taps Debut Fund For KemPharm
11/3/2008		Investing outside the box

September 16-18, 2009		BioPharm America 2009
November 11-12, 2009		Midamerica Healthcare Venture Forum
November 17-19, 2009		Windhover Therapeutic Area Partnership Conference
January 11-14, 2010		J.P. Morgan 28th Annual Healthcare Conference
February 23-25, 2010		BioWindhover Partnering Conference/Pharmaceutical Strategic Outlook
March 8-10, 2010		Bio-Europe Spring 2010
May 3-6, 2010		BIO International Convention